Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Sumitomo Dainippon Pharma in the Drug Discovery & Development Pharma 50

Sumitomo Dainippon Pharma

Rank: 42

2021 Rank: 36

Osaka, Japan
www.ds-pharma.com

2021 Revenues ($USD) : $4,697,305,171
2021 Revenues (foreign currencies) : JP¥515,952,000,000
2021 R&D spend : $1,207,957,028.40
2021 Number of Employees : 3067
Fiscal Year End : 3/31/2021
Leader : CEO Hiroshi Nomura

The Osaka, Japan–based company traces its origin to the 2005 merger of Sumitomo Pharmaceuticals and Dainippon Pharmaceuticals. The company has steadily expanded since that merger, acquiring the U.S. firm Sepracor Inc. (now Sunovion) in 2009 and ​​the oncology-focused biotech Boston Biomedical in 2012. The firm entered the field of regenerative medicine and cell therapy a year later. The company currently focuses on psychiatry and neurology, oncology and regenerative medicine/cell therapy. —BB

Sumitomo Dainippon Pharma

[Sumitomo Dainippon Pharma head office in Osaka, Japan. Image courtesy of Wikipedia.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE